RCUS Insider Trading

Insider Ownership Percentage: 12.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $2,758,976.83

Arcus Biosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Arcus Biosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arcus Biosciences Share Price & Price History

Current Price: $28.94
Price Change: Price Increase of +1.12 (4.03%)
As of 10/6/2022 04:39 PM ET

This chart shows the closing price history over time for RCUS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arcus Biosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/16/2022Jennifer JarrettCOOSell12,677$26.28$333,151.56130,942View SEC Filing Icon  
6/16/2022Carolyn C TangGeneral CounselSell1,400$20.72$29,008.0025,431View SEC Filing Icon  
6/16/2022Jennifer JarrettCOOSell6,081$20.72$125,998.32125,233View SEC Filing Icon  
6/16/2022Juan C. JaenPresidentSell2,333$20.72$48,339.76212,574View SEC Filing Icon  
6/16/2022Terry J. RosenCEOSell4,241$20.72$87,873.52232,329View SEC Filing Icon  
3/16/2022Jennifer JarrettCOOSell9,617$31.62$304,089.54View SEC Filing Icon  
12/20/2021Jennifer JarrettCOOSell34,822$41.48$1,444,416.56View SEC Filing Icon  
12/16/2021Carolyn C TangGeneral CounselSell487$39.82$19,392.34View SEC Filing Icon  
12/16/2021Jennifer JarrettCOOSell5,560$39.82$221,399.20View SEC Filing Icon  
12/16/2021Juan C. JaenPresidentSell865$39.82$34,444.30View SEC Filing Icon  
12/16/2021Robert C Goeltz IICFOSell485$39.83$19,317.55View SEC Filing Icon  
12/16/2021Terry J. RosenCEOSell2,299$39.82$91,546.18View SEC Filing Icon  
9/20/2021Jennifer JarrettCOOSell30,634$35.18$1,077,704.12View SEC Filing Icon  
6/16/2021Carolyn C. TangGeneral CounselSell1,309$24.16$31,625.44View SEC Filing Icon  
6/4/2021Jennifer JarrettCOOSell1,044$24.91$26,006.04View SEC Filing Icon  
4/23/2021Yasunori KanekoDirectorBuy4,133$31.37$129,652.216,717View SEC Filing Icon  
3/31/2021Kathryn E FalbergDirectorBuy20,000$28.35$567,000.0080,504View SEC Filing Icon  
3/16/2021Jennifer JarrettCOOSell8,661$35.03$303,394.83116,973View SEC Filing Icon  
3/16/2021William GrossmanInsiderSell2,127$35.03$74,508.8110,850View SEC Filing Icon  
1/31/2021Gilead Sciences IncMajor ShareholderBuy5,650,000$39.00$220,350,000.0013,913,029View SEC Filing Icon  
12/16/2020William GrossmanInsiderSell2,117$31.35$66,367.95View SEC Filing Icon  
9/9/2020Robert C Goeltz IICFOBuy5,000$21.57$107,850.005,000View SEC Filing Icon  
7/31/2020William GrossmanInsiderBuy200$19.72$3,944.00500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arcus Biosciences (NYSE:RCUS)

72.61% of Arcus Biosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RCUS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arcus Biosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/30/2022Verition Fund Management LLC150,496$3.81M0.1%N/A0.209%Search for SEC Filing on Google Icon
8/23/2022Captrust Financial Advisors2,072$53K0.0%+402.9%0.003%Search for SEC Filing on Google Icon
8/22/2022Legal & General Group Plc137,216$3.48M0.0%+269.8%0.190%Search for SEC Filing on Google Icon
8/22/2022ExodusPoint Capital Management LP69,387$1.76M0.0%+132.9%0.096%Search for SEC Filing on Google Icon
8/18/2022Goldman Sachs Group Inc.974,132$24.69M0.0%+295.3%1.350%Search for SEC Filing on Google Icon
8/16/2022Captrust Financial Advisors2,072$53K0.0%+402.9%0.003%Search for SEC Filing on Google Icon
8/16/2022Thrivent Financial for Lutherans45,799$1.16M0.0%N/A0.063%Search for SEC Filing on Google Icon
8/16/2022Price T Rowe Associates Inc. MD17,701$0.45M0.0%-8.9%0.025%Search for SEC Filing on Google Icon
8/16/2022Prudential Financial Inc.61,487$1.56M0.0%+163.4%0.085%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC187,717$4.76M1.3%+29.3%0.260%Search for SEC Filing on Google Icon
8/15/2022AQR Capital Management LLC70,333$1.78M0.0%N/A0.097%Search for SEC Filing on Google Icon
8/15/2022State Street Corp4,435,849$112.40M0.0%+61.3%6.147%Search for SEC Filing on Google Icon
8/15/2022PDT Partners LLC27,618$0.70M0.1%N/A0.038%Search for SEC Filing on Google Icon
8/15/2022Acuta Capital Partners LLC167,500$4.24M2.4%N/A0.232%Search for SEC Filing on Google Icon
8/15/2022Capital Impact Advisors LLC8,069$0.20M0.2%N/A0.011%Search for SEC Filing on Google Icon
8/15/2022Cubist Systematic Strategies LLC116,182$2.94M0.0%+137.6%0.161%Search for SEC Filing on Google Icon
8/15/2022UBS Asset Management Americas Inc.450,555$11.42M0.0%+43.6%0.624%Search for SEC Filing on Google Icon
8/15/2022Bain Capital Public Equity Management II LLC148,887$3.77M0.2%-20.6%0.206%Search for SEC Filing on Google Icon
8/13/2022Zurcher Kantonalbank Zurich Cantonalbank 11,859$0.30M0.0%-3.7%0.016%Search for SEC Filing on Google Icon
8/13/2022American International Group Inc.27,477$0.70M0.0%+23.4%0.038%Search for SEC Filing on Google Icon
8/12/2022Northern Trust Corp681,550$17.27M0.0%+13.5%0.944%Search for SEC Filing on Google Icon
8/12/2022Virtus ETF Advisers LLC5,029$0.13M0.0%+27.2%0.007%Search for SEC Filing on Google Icon
8/12/2022Credit Suisse AG29,433$0.75M0.0%-8.2%0.041%Search for SEC Filing on Google Icon
8/12/2022Rafferty Asset Management LLC155,056$3.93M0.0%-4.0%0.215%Search for SEC Filing on Google Icon
8/12/2022FMR LLC3,321,156$84.16M0.0%+0.0%4.602%Search for SEC Filing on Google Icon
8/12/2022Public Sector Pension Investment Board86,296$2.19M0.0%N/A0.120%Search for SEC Filing on Google Icon
8/12/2022BNP Paribas Arbitrage SA63,753$1.62M0.0%+509.4%0.088%Search for SEC Filing on Google Icon
8/12/2022Rhumbline Advisers145,747$3.69M0.0%+139.6%0.202%Search for SEC Filing on Google Icon
8/11/2022AlphaCrest Capital Management LLC126,234$3.20M0.2%N/A0.175%Search for SEC Filing on Google Icon
8/11/2022Trexquant Investment LP8,190$0.21M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/11/2022Deutsche Bank AG207,331$5.25M0.0%+3.1%0.287%Search for SEC Filing on Google Icon
8/11/2022UBS Group AG78,078$1.98M0.0%-59.7%0.108%Search for SEC Filing on Google Icon
8/11/2022Alps Advisors Inc.42,549$1.08M0.0%-41.7%0.059%Search for SEC Filing on Google Icon
8/10/2022Mutual of America Capital Management LLC7,830$0.20M0.0%N/A0.011%Search for SEC Filing on Google Icon
8/10/20221492 Capital Management LLC30,750$0.78M0.5%N/A0.043%Search for SEC Filing on Google Icon
8/10/2022Principal Financial Group Inc.331,777$8.41M0.0%+3,891.5%0.460%Search for SEC Filing on Google Icon
8/9/2022Swiss National Bank100,496$2.55M0.0%+10.1%0.139%Search for SEC Filing on Google Icon
8/9/2022Pictet Asset Management SA1,912,551$48.46M0.1%+23.0%2.650%Search for SEC Filing on Google Icon
8/8/2022Texas Permanent School Fund33,694$0.85M0.0%N/A0.047%Search for SEC Filing on Google Icon
8/8/2022Islay Capital Management LLC3,503$89K0.1%N/A0.005%Search for SEC Filing on Google Icon
8/5/2022State Board of Administration of Florida Retirement System19,122$0.49M0.0%+12.7%0.027%Search for SEC Filing on Google Icon
8/2/2022Comerica Bank39,465$1.13M0.0%N/A0.055%Search for SEC Filing on Google Icon
8/1/2022New York State Teachers Retirement System73,851$1.87M0.0%N/A0.103%Search for SEC Filing on Google Icon
8/1/2022Victory Capital Management Inc.15,762$0.40M0.0%-8.5%0.022%Search for SEC Filing on Google Icon
8/1/2022Maryland State Retirement & Pension System18,890$0.48M0.0%N/A0.026%Search for SEC Filing on Google Icon
8/1/2022Yousif Capital Management LLC40,338$1.02M0.0%N/A0.056%Search for SEC Filing on Google Icon
7/29/2022SG Americas Securities LLC37,557$0.95M0.0%-60.1%0.052%Search for SEC Filing on Google Icon
7/28/2022Arizona State Retirement System11,555$0.29M0.0%+10.6%0.016%Search for SEC Filing on Google Icon
7/27/2022Robeco Institutional Asset Management B.V.20,675$0.52M0.0%N/A0.029%Search for SEC Filing on Google Icon
7/26/2022Mirae Asset Global Investments Co. Ltd.13,572$0.34M0.0%-54.4%0.019%Search for SEC Filing on Google Icon
7/26/2022Everence Capital Management Inc.10,060$0.26M0.0%N/A0.014%Search for SEC Filing on Google Icon
7/26/2022KBC Group NV4,028$0.10M0.0%N/A0.006%Search for SEC Filing on Google Icon
7/25/2022Allspring Global Investments Holdings LLC9,882$0.25M0.0%-49.5%0.014%Search for SEC Filing on Google Icon
7/25/2022Oregon Public Employees Retirement Fund15,300$0.39M0.0%N/A0.021%Search for SEC Filing on Google Icon
7/25/2022Strs Ohio34,300$0.87M0.0%N/A0.048%Search for SEC Filing on Google Icon
7/8/2022State of Alaska Department of Revenue35,260$0.89M0.0%N/A0.049%Search for SEC Filing on Google Icon
6/30/2022Amalgamated Bank5,409$0.17M0.0%-7.3%0.008%Search for SEC Filing on Google Icon
6/7/2022Bank of America Corp DE137,461$4.34M0.0%+41.0%0.192%Search for SEC Filing on Google Icon
6/2/2022Mirae Asset Global Investments Co. Ltd.29,753$0.94M0.0%N/A0.041%Search for SEC Filing on Google Icon
5/18/2022BNP Paribas Arbitrage SA10,462$0.33M0.0%-39.4%0.015%Search for SEC Filing on Google Icon
5/17/2022Jane Street Group LLC24,861$0.79M0.0%-597.2%0.035%Search for SEC Filing on Google Icon
5/17/2022Point72 Hong Kong Ltd7,774$0.25M0.0%+1,631.4%0.011%Search for SEC Filing on Google Icon
5/17/2022Royal Bank of Canada2,772$88K0.0%-63.1%0.004%Search for SEC Filing on Google Icon
5/17/2022Sessa Capital IM L.P.181,000$5.71M0.3%N/A0.252%Search for SEC Filing on Google Icon
5/17/2022Endurant Capital Management LP38,650$1.22M0.3%N/A0.054%Search for SEC Filing on Google Icon
5/17/2022Gilder Gagnon Howe & Co. LLC291,280$9.19M0.1%-0.5%0.406%Search for SEC Filing on Google Icon
5/16/2022California State Teachers Retirement System52,736$1.66M0.0%-8.5%0.074%Search for SEC Filing on Google Icon
5/16/2022Goldman Sachs Group Inc.246,440$7.78M0.0%+119.1%0.344%Search for SEC Filing on Google Icon
5/16/2022Woodline Partners LP261,419$8.25M0.1%-84.7%0.365%Search for SEC Filing on Google Icon
5/16/2022State Street Corp2,749,919$86.79M0.0%+25.5%3.834%Search for SEC Filing on Google Icon
5/16/2022Engineers Gate Manager LP23,367$0.74M0.0%N/A0.033%Search for SEC Filing on Google Icon
5/16/2022Vident Investment Advisory LLC29,125$0.92M0.0%+20.0%0.041%Search for SEC Filing on Google Icon
5/16/2022Invesco Ltd.293,474$9.26M0.0%+47.7%0.409%Search for SEC Filing on Google Icon
5/16/2022UBS Group AG193,879$6.12M0.0%+3,237.0%0.270%Search for SEC Filing on Google Icon
5/16/2022Granahan Investment Management LLC226,050$7.13M0.2%+64.5%0.315%Search for SEC Filing on Google Icon
5/13/2022Bellevue Group AG111,700$3.53M0.0%+27.7%0.156%Search for SEC Filing on Google Icon
5/13/2022Northern Trust Corp600,408$18.95M0.0%-3.8%0.837%Search for SEC Filing on Google Icon
5/13/2022Charles Schwab Investment Management Inc.330,651$10.44M0.0%+2.6%0.461%Search for SEC Filing on Google Icon
5/13/2022Lazard Asset Management LLC2,436$76K0.0%N/A0.003%Search for SEC Filing on Google Icon
5/13/2022First Trust Advisors LP51,889$1.64M0.0%-67.3%0.072%Search for SEC Filing on Google Icon
5/13/2022Federated Hermes Inc.3,541$0.11M0.0%-74.1%0.005%Search for SEC Filing on Google Icon
5/13/2022American International Group Inc.22,258$0.70M0.0%-6.6%0.031%Search for SEC Filing on Google Icon
5/13/2022Parkman Healthcare Partners LLC167,321$5.28M1.5%+42.9%0.233%Search for SEC Filing on Google Icon
5/13/2022Ergoteles LLC39,966$1.26M0.0%N/A0.056%Search for SEC Filing on Google Icon
5/13/2022Vanguard Group Inc.3,512,114$110.84M0.0%+2.5%4.897%Search for SEC Filing on Google Icon
5/13/2022Sei Investments Co.45,343$1.43M0.0%-9.6%0.063%Search for SEC Filing on Google Icon
5/13/2022Dimensional Fund Advisors LP437,969$13.83M0.0%+77.0%0.611%Search for SEC Filing on Google Icon
5/12/2022Great West Life Assurance Co. Can1,816$61K0.0%-27.6%0.003%Search for SEC Filing on Google Icon
5/12/2022BlackRock Inc.4,139,526$130.64M0.0%+0.2%5.773%Search for SEC Filing on Google Icon
5/12/2022Rhumbline Advisers60,820$1.92M0.0%-7.0%0.085%Search for SEC Filing on Google Icon
5/12/2022Panagora Asset Management Inc.164,303$5.19M0.0%+5.6%0.229%Search for SEC Filing on Google Icon
5/12/2022Metropolitan Life Insurance Co NY2,996$95K0.0%-75.3%0.004%Search for SEC Filing on Google Icon
5/12/2022MetLife Investment Management LLC25,039$0.79M0.0%+57.4%0.035%Search for SEC Filing on Google Icon
5/12/2022E Fund Management Co. Ltd.8,105$0.26M0.0%N/A0.011%Search for SEC Filing on Google Icon
5/12/2022Connor Clark & Lunn Investment Management Ltd.212,743$6.71M0.0%-20.2%0.297%Search for SEC Filing on Google Icon
5/12/2022Blueshift Asset Management LLC8,327$0.26M0.0%N/A0.012%Search for SEC Filing on Google Icon
5/11/2022American Century Companies Inc.117,715$3.72M0.0%+1.7%0.164%Search for SEC Filing on Google Icon
5/11/2022Bank of New York Mellon Corp210,835$6.65M0.0%-12.2%0.294%Search for SEC Filing on Google Icon
5/11/2022Handelsbanken Fonder AB8,500$0.27M0.0%-30.9%0.012%Search for SEC Filing on Google Icon
5/11/2022GSA Capital Partners LLP15,809$0.50M0.1%+154.6%0.022%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arcus Biosciences logo
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for monotherapy. The company also develops Domvanalimab, an anti-TIGIT monoclonal antibody, which is in Phase 2 development for the treatment of first-line metastatic non-small cell lung cancer in combination with Zimberelimab; Quemliclustat, a small-molecule CD73 inhibitor is in a Phase 1/1b study for the treatment of first-line metastatic pancreatic cancer; and AB521, an oral and small molecule HIF-2a inhibitor that is in Phase 1 study for the treatment of patients with von Hippel- Lindau disease. It has a clinical development collaboration agreement with Strata Oncology, Inc. to evaluate Zimberelimab; a collaboration with AstraZeneca, BVF Partners L.P to evaluate domvanalimab, its investigational anti-TIGIT antibody, in combination with Imfinzi (durvalumab) in a registrational Phase 3 clinical trial in patients with unresectable Stage III non-small cell lung cancer; and license agreements with Taiho Pharmaceutical Co., Ltd, Abmuno Therapeutics LLC, and WuXi Biologics to develop anti-CD39 antibody for the treatment of cancer. The company was incorporated in 2015 and is headquartered in Hayward, California.
Read More on Arcus Biosciences

Today's Range

Now: $28.94
Low: $27.26
High: $29.13

50 Day Range

MA: $25.85
Low: $23.23
High: $28.00

52 Week Range

Now: $28.94
Low: $16.74
High: $49.10

Volume

17,766 shs

Average Volume

662,106 shs

Market Capitalization

$2.09 billion

P/E Ratio

40.76

Dividend Yield

N/A

Beta

0.66

Who are the company insiders with the largest holdings of Arcus Biosciences?

Arcus Biosciences' top insider shareholders include:
  1. Gilead Sciences Inc (Major Shareholder)
  2. Terry J Rosen (CEO)
  3. Juan C Jaen (President)
  4. Jennifer Jarrett (COO)
  5. Kathryn E Falberg (Director)
  6. Carolyn C Tang (General Counsel)
  7. William Grossman (Insider)
  8. Yasunori Kaneko (Director)
  9. Carolyn C Tang (General Counsel)
  10. Robert C Goeltz II (CFO)
Learn More about top insider investors at Arcus Biosciences.